Intermediate-High Risk Pulmonary Embolism

Rosa Mirambeaux, Francisco León, Behnood Bikdeli, Raquel Morillo, Deisy Barrios, Edwin Mercedes, Lisa Moores, Victor Tapson, Roger D Yusen, David Jiménez, Rosa Mirambeaux, Francisco León, Behnood Bikdeli, Raquel Morillo, Deisy Barrios, Edwin Mercedes, Lisa Moores, Victor Tapson, Roger D Yusen, David Jiménez

Abstract

Limited information exists about the prevalence, management, and outcomes of intermediate-high risk patients with acute pulmonary embolism (PE). In a prospective cohort study, we evaluated consecutive patients with intermediate-high risk PE at a large, tertiary, academic medical center between January 1, 2015 and March 31, 2019. Adjudicated outcomes included PE-related mortality and a complicated course through 30 days after initiation of PE treatment. Repeat systolic blood pressure (SBP), heart rate (HR), brain natriuretic peptide (BNP), and cardiac troponin I (cTnI) measurements, and echocardiography were performed within 48 hours after diagnosis. Among 1,015 normotensive patients with acute PE, 97 (9.6%) had intermediate-high risk PE. A 30-day complicated course and 30-day PE-related mortality occurred in 23 (24%) and 7 patients (7.2%) with intermediate-high risk PE. Seventeen (18%) intermediate-high risk patients received reperfusion therapy. Within 48 hours after initiation of anticoagulation, normalization of SBP, HR, cTnI, BNP, and echocardiography occurred in 82, 86, 78, 72, and 33% of survivors with intermediate-high risk PE who did not receive immediate thrombolysis. A complicated course between day 2 and day 30 after PE diagnosis for the patients who normalized SBP, HR, cTnI, BNP, and echocardiography measured at 48 hours occurred in 2.9, 1.4, 4.5, 3.3, and 14.3%, respectively. Intermediate-high risk PE occurs in approximately one-tenth of patients with acute symptomatic PE, and is associated with high morbidity and mortality. Normalization of HR 48 hours after diagnosis might identify a group of patients with a very low risk of deterioration during the first month of follow-up.

Keywords: intermediate-high risk; prognosis; pulmonary embolism; survival.

Conflict of interest statement

Conflict of Interest None declared.

Figures

Fig. 1
Fig. 1
Patient flow diagram. PE, pulmonary embolism.

References

    1. Kucher N, Rossi E, De Rosa M, Goldhaber S Z. Massive pulmonary embolism. Circulation. 2006;113(04):577–582.
    1. Goldhaber S Z, Visani L, De Rosa M.Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet 1999353(9162):1386–1389.
    1. Jiménez D, Bikdeli B, Barrios D et al.Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism. Int J Cardiol. 2018;269:327–333.
    1. Konstantinides S V, Torbicki A, Agnelli Get al.2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism Eur Heart J 201435433033–3069., 3069a–3069k
    1. Jiménez D, Aujesky D, Moores L et al.Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax. 2011;66(01):75–81.
    1. Bova C, Sanchez O, Prandoni P et al.Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J. 2014;44(03):694–703.
    1. Jimenez D, Lobo J L, Fernandez-Golfin C et al.Effectiveness of prognosticating pulmonary embolism using the ESC algorithm and the Bova score. Thromb Haemost. 2016;115(04):827–834.
    1. Becattini C, Agnelli G, Lankeit M et al.Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J. 2016;48(03):780–786.
    1. Remy-Jardin M, Remy J, Wattinne L, Giraud F. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique--comparison with pulmonary angiography. Radiology. 1992;185(02):381–387.
    1. PIOPED Investigators.Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED) JAMA 1990263202753–2759.
    1. Kearon C, Ginsberg J S, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med. 1998;129(12):1044–1049.
    1. Jiménez D, Aujesky D, Moores L et al.Simplification of the Pulmonary Embolism Severity Index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383–1389.
    1. Jiménez D, Kopecna D, Tapson V et al.Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med. 2014;189(06):718–726.
    1. Grifoni S, Olivotto I, Cecchini P et al.Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000;101(24):2817–2822.
    1. Jiménez D, Díaz G, Molina J et al.Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism. Eur Respir J. 2008;31(04):847–853.
    1. Pieralli F, Olivotto I, Vanni S et al.Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol. 2006;97(09):1386–1390.
    1. Scridon T, Scridon C, Skali H, Alvarez A, Goldhaber S Z, Solomon S D. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol. 2005;96(02):303–305.
    1. Binder L, Pieske B, Olschewski M et al.N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation. 2005;112(11):1573–1579.
    1. Dellas C, Tschepe M, Seeber V et al.A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism. Thromb Haemost. 2014;111(05):996–1003.
    1. Konstantinides S V, Meyer G, Becattini Cet al.2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)Eur Heart J2019. Doi: 10.1093/eurheartj/ehz405 [Epub ahead of print]
    1. Meyer G, Vicaut E, Danays T et al.Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370(15):1402–1411.
    1. Kearon C, Akl E A, Ornelas J et al.Antithrombotic therapy for VTE disease: Chest guideline and expert panel report. Chest. 2016;149(02):315–352.
    1. Jiménez D, Bikdeli B, Barrios D et al.Management appropriateness and outcomes of patients with acute pulmonary embolism. Eur Respir J. 2018;51(05):1.800445E6.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa